Promestriene

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Logo pink
Stay in the know!
As part of our commitment to providing the most up-to-date drug information, we will be releasing #DrugBankUpdates with our newly added curated drug pages.
#DrugBankUpdates
Name
Promestriene
Accession Number
DB12487
Type
Small Molecule
Groups
Investigational
Description

Promestriene has been used in trials studying the prevention of Hypospadias.

Synonyms
  • Promestrieno
Categories
UNII
GXM4PER6WZ
CAS number
39219-28-8
Weight
Not Available
Chemical Formula
Not Available
InChI Key
Not Available
InChI
Not Available
IUPAC Name
Not Available
SMILES
Not Available

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
(R)-warfarinPromestriene may decrease the anticoagulant activities of (R)-warfarin.
(S)-WarfarinPromestriene may decrease the anticoagulant activities of (S)-Warfarin.
4-hydroxycoumarinPromestriene may decrease the anticoagulant activities of 4-hydroxycoumarin.
AbciximabPromestriene may decrease the anticoagulant activities of Abciximab.
AbituzumabPromestriene may increase the thrombogenic activities of Abituzumab.
AbrilumabPromestriene may increase the thrombogenic activities of Abrilumab.
AceclofenacAceclofenac may increase the thrombogenic activities of Promestriene.
AcenocoumarolPromestriene may decrease the anticoagulant activities of Acenocoumarol.
AcetohexamideThe therapeutic efficacy of Acetohexamide can be decreased when used in combination with Promestriene.
Acetylsalicylic acidPromestriene may decrease the anticoagulant activities of Acetylsalicylic acid.
Additional Data Available
  • Extended Description
    Extended Description

    Extended description of the mechanism of action and particular properties of each drug interaction.

    Learn more
  • Severity
    Severity

    A severity rating for each drug interaction, from minor to major.

    Learn more
  • Evidence Level
    Evidence Level

    A rating for the strength of the evidence supporting each drug interaction.

    Learn more
  • Action
    Action

    An effect category for each drug interaction. Know how this interaction affects the subject drug.

    Learn more
Food Interactions
Not Available

References

General References
Not Available
External Links
PubChem Substance
347911337
Wikipedia
Promestriene
ATC Codes
G03CA09 — Promestriene

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
3CompletedPreventionHypospadias1
4CompletedSupportive CareAtrophic Vaginitis / Endometrial Hyperplasia / Pelvic Organ Prolapse (POP)1
4TerminatedTreatmentBacterial Vaginosis (BV)1
Not AvailableNot Yet RecruitingNot AvailableVulvovaginal Atrophy1
Not AvailableRecruitingTreatmentBreast Cancer / Vulva; Atrophy / Vulvovaginal Atrophy1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
Not Available
Predicted ADMET features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Taxonomy

Classification
Not classified

Drug created on October 20, 2016 16:34 / Updated on November 02, 2019 02:59